Page 56 - ஒன்றுபட்டது மாநிலங்களில் துறை ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article BETHESDA, Md., Jan. 15, 2021 /PRNewswire/  Dr. Paul E. Love, an NIH investigator from Bethesda, Maryland, conducts research that is testing if human T Cell Receptor (TCR) signaling components and TCR signal modifying proteins can serve as targets for immunotherapy. This research, which could result in a ground-breaking step forward in immunotherapy, focuses on the signaling apparatus of the TCR, the receptor responsible for activation of T lymphocytes which perform critical functions in pathogen resistance and tumor surveillance. Dr. Love has amassed more than 31 years of experience as a researcher. He specializes in immunology and is credited with an abundance of research work relevant to basic science and medicine. Dr. Love practices at the National Institute of Health (NIH), a federal agency affiliated with the United States Department of Health and Human Services.

United statesEunice kennedy shriverHuman developmentUnited states department of healthWashington universityNational institute of healthHuman servicesNational institute of child healthNational instituteUnited states departmentSenior investigatorChild healthHuman geneticsDr paule loveஒன்றுபட்டது மாநிலங்களில்யூனிஸ் கெந்நெடீ ஶ்ரைவர்